Search

everythinglearnresearchcommunity

for

Search:↓

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

Melatonin can increase cashmere yield by altering gene expression and restarting the growth cycle early.

The May issue discussed publishing agreements and four studies on cholesterol in hair, cancer cell changes, hormones in the uterus, and skin protein effects.

Melatonin applied to the scalp helps increase hair density in people with early hair loss.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Some nonsurgical hair loss treatments are effective, especially if started early.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

PCOS is a hormonal issue in women that is usually treated with birth control pills, metformin, and lifestyle changes, with early treatment helping to reduce complications and improve life quality.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.